Mentice Past Earnings Performance

Past criteria checks 0/6

Mentice's earnings have been declining at an average annual rate of -2.9%, while the Healthcare Services industry saw earnings growing at 6.8% annually. Revenues have been growing at an average rate of 15.8% per year.

Key information

-2.9%

Earnings growth rate

0.3%

EPS growth rate

Healthcare Services Industry Growth7.9%
Revenue growth rate15.8%
Return on equity-16.8%
Net Margin-8.4%
Next Earnings Update13 Feb 2025

Recent past performance updates

Recent updates

Revenue & Expenses Breakdown

How Mentice makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

DB:MN2 Revenue, expenses and earnings (SEK Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Sep 24276-232370
30 Jun 24282-102300
31 Mar 24256-262230
31 Dec 23275-32110
30 Sep 2327322010
30 Jun 23261-61990
31 Mar 23230-251950
31 Dec 22219-311920
30 Sep 22215-371900
30 Jun 22205-361770
31 Mar 22207-241630
31 Dec 21185-291530
30 Sep 21165-221410
30 Jun 21158-151320
31 Mar 21136-211240
31 Dec 20138-131220
30 Sep 20152-91260
30 Jun 20148-171350
31 Mar 20156-171430
31 Dec 19149-211430
30 Sep 19154-11350
30 Jun 1916181280
31 Mar 19156141220
31 Dec 18157201160
31 Dec 171096830

Quality Earnings: MN2 is currently unprofitable.

Growing Profit Margin: MN2 is currently unprofitable.


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: MN2 is unprofitable, and losses have increased over the past 5 years at a rate of 2.9% per year.

Accelerating Growth: Unable to compare MN2's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: MN2 is unprofitable, making it difficult to compare its past year earnings growth to the Healthcare Services industry (3.6%).


Return on Equity

High ROE: MN2 has a negative Return on Equity (-16.79%), as it is currently unprofitable.


Return on Assets


Return on Capital Employed


Discover strong past performing companies